Matt is a Principal at Samsara, where he leads the firm’s public equity strategy. He joined in 2025, bringing over two decades of combined experience in healthcare investing and scientific research. Before joining Samsara, Matt held investment roles at ArrowMark Partners, GMT Capital, and RBC Capital Markets, and earlier in his career, conducted research on the genetics of early brain development and circuit-level plasticity.
Matt received a BS in Biology from the University of North Carolina at Chapel Hill, a PhD in Molecular Biology from UC Santa Cruz, and completed his postdoctoral work in neuroscience at UC San Diego.